scorecardresearch
Add as a preferred source on Google
Tuesday, December 2, 2025
TopicBaba Ramdev

Topic: Baba Ramdev

Patanjali ad case saw flouting of rules. India needs to fix its Magic Remedies Act

The IMA has said that through repeated advertisements, Patanjali had been disparaging modern medicine while offering a permanent solution for lifestyle disorders.

SC declines apology affidavits of Ramdev, Balakrishnan in Patanjali misleading ads case

In two separate affidavits filed, Ramdev and Balkrishna have tendered an unqualified apology for the 'breach of the statement' recorded in 21 November, 2023 order of the apex court.

Don’t let just Ramdev’s Patanjali take the fall. Allopathy isn’t immune to ‘misleading’ ads

The Indian Medical Association and other allopathic doctors have no moral basis to cast aspersions on Ayurveda or AYUSH companies.

‘Absolute defiance,’ SC berates Baba Ramdev, Acharya Balakrishna in Patanjali misleading ads case

The top court also came down on the Central government questioning its silence over Patanjali's claim that there were no remedy for Covid in allopathy.

Patanjali MD Balkrishna apologises to SC over ‘misleading ads’, day after Baba Ramdev is summoned

Acharya Balkrishna says company regrets putting out the publicity campaign that questioned efficacy of modern medicine, but also termed the Drugs & Magic Remedies Act as 'archaic'.

Patanjali misleading ads: SC orders Baba Ramdev, Acharya Balkrishna to be present at next hearing

Indian Medical Association has accused Patanjali of carrying out a smear campaign on evidence-based medicine. Court noted that no response filed by Patanjali on its contempt notice.

SC slams Ramdev’s Patanjali over ‘misleading’ advertisements, issues notice

The bench cautioned Patanjali Ayurved from making any statements adverse to any system of medicine in media in any form.

Here’s why Nepal banned 16 Indian pharma companies, including Patanjali’s Divya Pharmaceuticals

Nepal had sent a team to India in April and July to inspect the manufacturing facilities of pharmaceutical firms that had applied to supply their products to the neighbouring country.

Orange bikinis are the new black & exchange student pranks ‘Vishwaguru’

The best cartoons of the day, chosen by the editors at ThePrint.

A constitution’s right to be forgotten & Bajwa ‘briefs’ Pakistani army one last time

The best cartoons of the day, chosen by the editors at ThePrint.

On Camera

RSS is warming up to Yogi Adityanath. CM has many more boxes to tick

It’s not just the Opposition parties Yogi Adityanath has to contend with. His detractors within the BJP are no less formidable.

Modi govt’s PM internship scheme saw high attrition in Year 1. Just 30% joined, 41% quit midway

According to government reply in Lok Sabha, the pilot phase of PMIS is being used to test concepts, strategies and systems before a full-scale implementation of the scheme.

After Op Sindoor, India goes in for more Heron Mk IIs; Israel frontrunner for mega MALE drones deal

Order for 87 MALE drones will be split between 2 Indian firms in 64:36 ratio to ensure there are 2 independent manufacturing lines with at least 60% indigenous components.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.